Heterogeneity of Histological Transformation Events in Waldenstrom's Macroglobulinemia (WM) and Related Disorders

被引:23
作者
Owen, R. G. [1 ]
Bynoe, A. G. [2 ]
Varghese, A. [1 ]
de Tute, R. M. [1 ]
Rawstron, A. C. [1 ]
机构
[1] St James Univ Hosp, HMDS Lab, St Jamess Inst Oncol, Leeds LS9 7TF, W Yorkshire, England
[2] Harrogate Dist Hosp, Harrogate, England
关键词
B-CELL LYMPHOMA; CHRONIC-LYMPHOCYTIC-LEUKEMIA; EPSTEIN-BARR-VIRUS; RICHTERS TRANSFORMATION; PROGNOSTIC-FACTORS; FLUDARABINE; CYCLOPHOSPHAMIDE; EVOLUTION; FEATURES; DISEASE;
D O I
10.3816/CLML.2011.n.042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Histological transformation, typically to diffuse large B-cell lymphoma (DLBCL) is reported to occur in 5%-10% of patients with WM and recent studies have highlighted a possible aetiological role for the nucleoside analogues. It is however becoming increasingly clear that histological transformation is a complex phenomenon and may include clonally unrelated disorders. In order to highlight this pathological heterogeneity we describe 5 patients with diverse histological progression events. These included EBV-associated events namely DLBCL, peripheral T-cell lymphoma and spontaneously resolving mucocutaneous ulcer. A further 2 patients demonstrated a localised plasma cell rich lesion simulating plasmacytoma and a de novo DLBCL arising in an unrelated B-cell clone. It is clear therefore that detailed pathological assessments are required in all suspected cases of transformation and that the pathological heterogeneity demonstrated by this study needs to be taken into account when potential aetiological factors are being assessed.
引用
收藏
页码:176 / 179
页数:4
相关论文
共 22 条
[1]   Phenotypic evolution of Waldenstrom's macroglobulinemia to extramedullary plasmacytoma [J].
Bashir, Qaiser ;
Lee, Choon-Kee ;
Stuart, Rodney W. ;
Smith, Maxwell L. ;
Ryder, John ;
Gonzalez, Ricardo .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) :2408-2410
[2]   EBV Positive Mucocutaneous Ulcer-A Study of 26 Cases Associated With Various Sources of Immunosuppression [J].
Dojcinov, Stefan D. ;
Venkataraman, Girish ;
Raffeld, Mark ;
Pittaluga, Stefania ;
Jaffe, Elaine S. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (03) :405-417
[3]   PROGNOSTIC FACTORS IN WALDENSTROM MACROGLOBULINEMIA - A REPORT OF 167 CASES [J].
FACON, T ;
BROUILLARD, M ;
DUHAMEL, A ;
MOREL, P ;
SIMON, M ;
JOUET, JP ;
BAUTERS, F ;
FENAUX, P .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1553-1558
[4]   IgM myeloma:: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14) [J].
Feyler, Sylvia ;
O'Connor, Sheila J. M. ;
Rawstron, Andy C. ;
Subash, Chezhian ;
Ross, Fiona M. ;
Pratt, Guy ;
Drayson, Mark T. ;
Ashcroft, John ;
Cook, Gordon ;
Owen, Roger G. .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (05) :547-551
[5]   Waldenstrom macroglobulinaemia:: presenting features and outcome in a series with 217 cases [J].
García-Sanz, R ;
Montoto, S ;
Torrequebrada, A ;
de Coca, AG ;
Petit, J ;
Sureda, A ;
Rodríguez-García, JA ;
Massó, P ;
Pérez-Aliaga, A ;
Monteagudo, MD ;
Navarro, I ;
Moreno, G ;
Toledo, C ;
Alonso, A ;
Besses, C ;
Besalduch, J ;
Jarque, I ;
Salama, P ;
Rivas, JAH ;
Navarro, B ;
Bladé, J ;
Miguel, JFS .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) :575-582
[6]  
Kremer M, 2003, LAB INVEST, V83, P107
[7]   Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: A report of 71 cases [J].
Leblond, V ;
Ben-Othman, T ;
Deconinck, E ;
Taksin, AL ;
Harousseau, JL ;
Delgado, MA ;
Delmer, A ;
Maloisel, F ;
Mariette, X ;
Morel, P ;
Clauvel, JP ;
Duboisset, P ;
Entezam, S ;
Hermine, O ;
Merlet, M ;
Yakoub-Agha, I ;
Guibon, O ;
Caspard, H ;
Fort, N .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2060-2064
[8]   Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease [J].
Leblond, V ;
Lévy, V ;
Maloisel, F ;
Cazin, B ;
Fermand, JP ;
Harousseau, JL ;
Remenieras, L ;
Porcher, R ;
Gardembas, M ;
Marit, G ;
Deconinck, E ;
Desablens, B ;
Guilhot, F ;
Philippe, G ;
Stamatoullas, A ;
Guibon, O .
BLOOD, 2001, 98 (09) :2640-2644
[9]   Balancing Risk Versus Benefit in the Treatment of Waldenstrom's Macroglobulinemia Patients with Nucleoside Analogue-Based Therapy [J].
Leleu, Xavier ;
Tamburini, Jerome ;
Roccaro, Aldo ;
Morel, Pierre ;
Soumerai, Jacob ;
Levy, Vincent ;
Wemeau, Mathieu ;
Balkaran, Sandy ;
Poulain, Stephanie ;
Hunter, Zachary R. ;
Ghobrial, Irene M. ;
Treon, Steven P. ;
Leblond, Veronique .
CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (01) :71-73
[10]   Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenstrom Macroglobulinemia Treated With Nucleoside Analogs [J].
Leleu, Xavier ;
Soumerai, Jacob ;
Roccaro, Aldo ;
Hatjiharissi, Evdoxia ;
Hunter, Zachary R. ;
Manning, Robert ;
Ciccarelli, Bryan T. ;
Sacco, Antonio ;
Ioakimidis, Leukothea ;
Adamia, Sophia ;
Moreau, Anne-Sophie ;
Patterson, Christopher J. ;
Ghobrial, Irene M. ;
Treon, Steven P. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) :250-255